Journal article

Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia

Iris LY Tung, Dorothy A Machalek, Suzanne M Garland



BACKGROUND: Human papillomavirus (HPV) vaccination targets high-risk HPV16/18 that cause 70% of all cancers of the cervix. In Australia there is a fully-funded, school-based National HPV Vaccination Program which has achieved vaccine initiation rate of 82% among age-eligible females. Improving HPV vaccination rates is important in the prevention of morbidity and mortality associated with HPV-related disease. This study aimed to identify factors and barriers associated with uptake of the HPV vaccine in the Australian Program. METHODS: Between 2011 and 2014, females aged 18-25 years, living in Victoria, Australia who were offered HPV vaccination between 2007 and 2009 as part of the National HP..

View full abstract


Awarded by Victorian Cancer Agency

Funding Acknowledgements

SMG received funding from the Victorian Cancer Agency TS10_04. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.We would like to acknowledge the Victorian Cancer Agency for their TS10_04 grant-2011-2013, Monitoring the effectiveness of the Australian cervical cancer vaccine programme: translation to reduction in vaccine-related HPV infection and precancerous cervical lesions. We thank members of the VACCINE study group for project management and coordination, participants of the VACCINE study for their contribution to data of this study and Athena Costa for assisting with the manuscript submission. We thank the NHVPR staff who assisted with the study. The NHVPR is owned by the Australian Government Department of Health and operated by the Victorian Cytology Service.